M12.059
BillableChronic postrheumatic arthropathy [Jaccoud], unspecified hip
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is M12.059 an HCC code?
Yes. M12.059 maps to Reactive and Specified Arthropathies under the CMS-HCC V28 risk adjustment model (and Rheumatoid Arthritis and Inflammatory Connective Tissue Disease under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for M12.059
For M12.059to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed M12.059 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
M12.059 is the ICD-10-CM diagnosis code for chronic postrheumatic arthropathy [jaccoud], unspecified hip. A chronic joint condition affecting the hip (side not specified) that develops after rheumatic fever, characterized by reversible joint deformities without permanent damage to the joint structures. M12.059 sits in the ICD-10-CM chapter for diseases of the musculoskeletal system and connective tissue (m00-m99), within the section covering inflammatory polyarthropathies (m05-m14).
Under the CMS-HCC V28 risk adjustment model, M12.059 maps to Reactive and Specified Arthropathies (HCC 94) with a community, non-dual, aged base RAF weight of 0.000. Under the older CMS-HCC V24 model, M12.059 maps to Rheumatoid Arthritis and Inflammatory Connective Tissue Disease (HCC 40) with a community, non-dual, aged base RAF weight of 0.307. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use only when laterality is not documented or cannot be determined. Because M12.059 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for M12.059 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use only when laterality is not documented or cannot be determined
- •Request clarification from provider if bilateral hip involvement is present, as coding each side separately may be warranted
Clinical Significance
Chronic postrheumatic arthropathy of unspecified hip indicates Jaccoud's arthropathy as a sequel to rheumatic fever, potentially causing significant mobility impairment and disability. This condition necessitates ongoing management of joint symptoms while maintaining vigilance for cardiac complications associated with rheumatic heart disease.
Documentation Requirements
- ✓Documented history of rheumatic fever
- ✓Hip involvement without laterality specification
- ✓Evidence of chronic joint deformity (reversible)
- ✓Clinical signs consistent with postrheumatic arthropathy
- ✓Absence of erosive changes on hip imaging
- ✓Assessment of hip function and mobility
- ✓Current cardiac status evaluation
- ✓Treatment response and ambulation assessment